Initial Evaluation of the Utility of Ferumoxytol for MR Runoffs
Thomas Hope 1 , Rizwan Aslam 1 , Judy Yee 1 , Anait Sesi 1 , Joseph Rapp 1 , Christopher Owens 1 , and David Saloner 1
Department of Radiology, UCSF/SFVA, San
Francisco, CA, United States
We describe the first use of Ferumoxytol as an MR
contrast agent for use in MR runoffs. In order to
minimize T2* effects, the agent must be diluted during
the dynamic arterial phases. When diluted, ferumoxytol
performs well as an alternative contrast agent in
patients with renal disease.
This abstract and the presentation materials are available to members only;
a login is required.